Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment
| Autor: | Westers, Theresia M., Alhan, Canan, Chamuleau, Martine E.D., van der Vorst, Maurice J.D.L., Eeltink, Corien, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A. |
|---|---|
| Zdroj: | In Blood 4 March 2010 115(9):1779-1784 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|